These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 16219044)

  • 1. Health economics of treating haemophilia A with inhibitors.
    Knight C
    Haemophilia; 2005 Nov; 11 Suppl 1():11-7. PubMed ID: 16219044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant factor VIIa (eptacog alfa): a pharmacoeconomic review of its use in haemophilia in patients with inhibitors to clotting factors VIII or IX.
    Lyseng-Williamson KA; Plosker GL
    Pharmacoeconomics; 2007; 25(12):1007-29. PubMed ID: 18047387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The economics of inpatient on-demand treatment for haemophilia with high-responding inhibitors: a US retrospective data analysis.
    Pokras SM; Petrilla AA; Weatherall J; Lee WC
    Haemophilia; 2012 Mar; 18(2):284-90. PubMed ID: 21812862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying and managing inhibitor patients requiring orthopaedic surgery - the multidisciplinary team approach.
    Ludlam C
    Haemophilia; 2005 Nov; 11 Suppl 1():7-10. PubMed ID: 16219043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case studies: orthopaedic surgery in adult patients with haemophilia A with inhibitors.
    Goddard N
    Haemophilia; 2005 Nov; 11 Suppl 1():32-7. PubMed ID: 16219049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orthopaedic surgery in haemophilia patients with inhibitors: a practical guide to haemostatic, surgical and rehabilitative care.
    Teitel JM; Carcao M; Lillicrap D; Mulder K; Rivard GE; St-Louis J; Smith F; Walker I; Zourikian N
    Haemophilia; 2009 Jan; 15(1):227-39. PubMed ID: 18752535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant activated factor VII for haemophilia patients with inhibitors undergoing orthopaedic surgery: a review of the literature.
    Obergfell A; Auvinen MK; Mathew P
    Haemophilia; 2008 Mar; 14(2):233-41. PubMed ID: 18081827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic evaluation of major knee surgery with recombinant activated factor VII in hemophilia patients with high titer inhibitors and advanced knee arthropathy: exploratory results via literature-based modeling.
    Ballal RD; Botteman MF; Foley I; Stephens JM; Wilke CT; Joshi AV
    Curr Med Res Opin; 2008 Mar; 24(3):753-68. PubMed ID: 18234151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cost minimization model for the treatment of minor bleeding episodes in patients with haemophilia A and high-titre inhibitors.
    Putnam KG; Bohn RL; Ewenstein BM; Winkelmayer WC; Avorn J
    Haemophilia; 2005 May; 11(3):261-9. PubMed ID: 15876272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managing acute bleeds in the patient with haemophilia and inhibitors: options, efficacy and safety.
    von Depka M
    Haemophilia; 2005 Nov; 11 Suppl 1():18-23. PubMed ID: 16219045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elective surgery in patients with congenital coagulopathies and inhibitors: experience of the National Haemophilia Centre of Venezuela.
    Boadas A; Fernández-Palazzi F; De Bosch NB; Cedeño M; Ruiz-Sáez A
    Haemophilia; 2011 May; 17(3):422-7. PubMed ID: 21118333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of inhibitors on the cost of clotting factor replacement therapy in Haemophilia A in Canada.
    Chang H; Sher GD; Blanchette VS; Teitel JM
    Haemophilia; 1999 Jul; 5(4):247-52. PubMed ID: 10469178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Approaches to successful total knee arthroplasty in haemophilia A patients with inhibitors.
    Konkle BA; Nelson C; Forsyth A; Hume E
    Haemophilia; 2002 Sep; 8(5):706-10. PubMed ID: 12199684
    [No Abstract]   [Full Text] [Related]  

  • 14. Current use of by-passing agents in Europe in the management of acute bleeds in patients with haemophilia and inhibitors.
    Astermark J; Rocino A; Von Depka M; Van Den Berg HM; Gringeri A; Mantovani LG; Morado M; Garrido RP; Schiavoni M; Villar A; Windyga J;
    Haemophilia; 2007 Jan; 13(1):38-45. PubMed ID: 17212723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost of care of haemophilia with inhibitors.
    Di Minno MN; Di Minno G; Di Capua M; Cerbone AM; Coppola A
    Haemophilia; 2010 Jan; 16(1):e190-201. PubMed ID: 19845772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health economics in haemophilia: a review from the clinician's perspective.
    Escobar MA
    Haemophilia; 2010 May; 16 Suppl 3():29-34. PubMed ID: 20586799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orthopaedic surgery in haemophilia patients with inhibitors as the last resort.
    Rodriguez-Merchan EC; Quintana M; Jimenez-Yuste V
    Haemophilia; 2008 Nov; 14 Suppl 6():56-67. PubMed ID: 19134035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emicizumab for the treatment of haemophilia A: a narrative review.
    Franchini M; Marano G; Pati I; Candura F; Profili S; Veropalumbo E; Masiello F; Catalano L; Piccinini V; Vaglio S; Pupella S; Liumbruno GM
    Blood Transfus; 2019 May; 17(3):223-228. PubMed ID: 31246563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired haemophilia: management of bleeds and immune therapy to eradicate autoantibodies.
    Holme PA; Brosstad F; Tjønnfjord GE
    Haemophilia; 2005 Sep; 11(5):510-5. PubMed ID: 16128896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of oral bleedings with recombinant factor VIIa in children with haemophilia A and inhibitor.
    Laguna P; Klukowska A
    Haemophilia; 2005 Jan; 11(1):2-4. PubMed ID: 15660981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.